Evidence map›Paper›PMID 40919301›Full record

ArticleJournal of vitreoretinal diseases

Real-World Experience of Geographic Atrophy Treatment With Avacincaptad Pegol.

Abdullah Abou-Samra, Muhi Dean Barazi, Amira Abbas, Omar Sabbagh, Yusuf Bade, Brian K Do, Jeanette Du, Jared Ebert, Jordana Fein, Joshua D Levinson and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vitreoretinal diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Abdullah Abou-SamraRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0009-0009-7810-8760
Muhi Dean BaraziRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0009-0007-7605-7715
Amira AbbasDepartment of Ophthalmology, Georgetown University School of Medicine, Washington, DC, USA.ORCID https://orcid.org/0009-0002-8951-6224
Omar SabbaghWest Virginia University, Morgantown, WV, USA.ORCID https://orcid.org/0009-0008-3443-329X
Yusuf BadeSchool of Medicine, George Washington University, Washington, DC, USA.
Brian K DoRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0000-0003-1707-6899
Jeanette DuRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0000-0001-6607-5660
Jared EbertRetina Group of Washington, Reston, VA, USA.
Jordana FeinRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0000-0001-7198-3823
Joshua D LevinsonRetina Group of Washington, Reston, VA, USA.
Alexander MelamudRetina Group of Washington, Reston, VA, USA.
Osama SabbaghRetina Group of Washington, Reston, VA, USA.
Mohsin H AliRetina Group of Washington, Reston, VA, USA.ORCID https://orcid.org/0000-0002-1077-2341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

age-related macular degenerationavacincaptad pegolcomplement inhibitiongeographic atrophyintraocular inflammationsafetyvasculitis

Identifiers

PMID40919301
PMCPMC12408533

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.